Treatment as Prevention¨

Means to an end

After what Shane Ryan calls “a silly, stupid weekend” in late April, he joined the many other men in San Francisco, California, who line up six mornings each week and wait for the doors to open at Magnet. Located in the city’s Castro district, Magnet provides sexual health services for gay and bisexual men. Last […]

Means to an end Read More »

bioLytical to Present Findings of Early HIV Detection

INSTI HIV Assay’s Unique Platform Promises Earlier HIV Detection bioLytical Laboratories Inc. announced today that its abstract highlighting early HIV detection using INSTI HIV-1/HIV-2 Antibody Test was accepted for presentation at the 8th Annual International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver. The results will be presented Wednesday, July 22nd

bioLytical to Present Findings of Early HIV Detection Read More »

HIV/AIDS scientist gets $1.5m US to study addiction in Vancouver and five other cities

A Canadian scientist has been awarded a $1.5-million-US research grant for a new five-year project to examine ways of preventing injection drug use and the spread of addiction. Dan Werb, a research scientist at the B.C. Centre for Excellence in HIV/AIDS, is one of four inaugural recipients of the prestigious Avenir Award from the U.S.

HIV/AIDS scientist gets $1.5m US to study addiction in Vancouver and five other cities Read More »

Panamá adopta programa de lucha contra el HIV/SIDA desarrollado en Vancouver, Canadá

Ciudad de Panamá (CBNnoticias) -El Gobierno de Panamá y el Centro para la Excelencia en HIV/SIDA de la Colombia Británica (BC- CfE sigla en inglŽs) con sede en Vancouver, Canadá, firmaron un memorando de entendimiento a travŽs del cual las autoridades sanitarias panameñas buscarán recibir el apoyo necesario para controlar esta enfermedad y reducir el

Panamá adopta programa de lucha contra el HIV/SIDA desarrollado en Vancouver, Canadá Read More »

Vancouver HIV Pioneer Addresses World Congress of Dermatology

VANCOUVER, BC–(Marketwired – June 08, 2015) – Dr. Julio Montaner, a Vancouver physician who is internationally recognized for his pioneering work in HIV/AIDS treatment and prevention, is today speaking to the World Congress of Dermatology (WCD) on the breakthrough therapeutic approach known as Treatment as Prevention (TasP). In his now famous TEDx talk of 2011,

Vancouver HIV Pioneer Addresses World Congress of Dermatology Read More »

Vancouver HIV Pioneer Addresses World Congress of Dermatology

VANCOUVER, BC –(Marketwired – June 08, 2015) – Dr. Julio Montaner, a Vancouver physician who is internationally recognized for his pioneering work in HIV/AIDS treatment and prevention, is today speaking to the World Congress of Dermatology (WCD) on the breakthrough therapeutic approach known as Treatment as Prevention (TasP). In his now famous TEDx talk of

Vancouver HIV Pioneer Addresses World Congress of Dermatology Read More »

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025